Motif Bio Share Discussion Threads

[scottdavid70] 23/10/2020 18:35

The BoD can’t guarantee a RTO can be completed by end of January 2021 but it can GUARANTEE it’s FULLY FUNDED on May 5th before then adding on the 12th October 2020 that there could be SIGNIFICANT DILUTION of half the company shares currently in issue? So what’s the truth here guys?

If they have no idea what they are needing but are fully funded how do they know there could be SIGNIFICANT DILUTION?

More questions will be asked and more investigations will be done because 2 and 2 should equal 4 but am struggling to make that addition work right now. Anyone else?

[scottdavid70] 23/10/2020 10:15

The optics here are terrible for the Board and in particular Lumsden. They will have to at some stage explain how this situation unfolded

[scottdavid70] 23/10/2020 10:13

Good for you Chuffer - let’s never let the Board and Lumsden forget what they said, what they have heralded and what they have tried to do whilst trying to steamroller shareholders rights whilst they have been the ones for responsible for the catastrophic share price decimation.

Times are changing. Look at what Marcus Rashford is achieving and here we will also through the publication of what has unfolded here from the beginning many years ago..the CEO getting more incentives in salary for fundraising than actually for getting Iclaprim approved for example, to change the way shareholders are dealt with. It will take a lot of effort on my part and money, thankfully I have enough to see it through, to expose what shareholders have endured here.

[chuffer2] 23/10/2020 09:25

1 day till it’s been a year since the much heralded US Army trials were shouted from the rooftops for Iclaprim. Nothing. Zero. Name one thing that Lumsden has done since the 14th February that has in anyway helped shareholders?

His idea of cost controls is very different to all of ours who keep getting diluted due to the company running out of money faster than it should have done if they hadn’t taken so much in salaries. Could have deferred their salaries to help leases the dilution but no that’s not the way greed works.

Lol, sorry, couldn’t resist

[scottdavid70] 22/10/2020 18:06

Please post any updates anyone has on the potential for SIGNIFICANT DILUTION as again surely it is the right of shareholders to know that their best interests are being looked after and how? We aren’t mushrooms here being kept in the dark unlawfully are we?

[scottdavid70] 22/10/2020 18:04

Anyone got a reply from the comma out the potential for SIGNIFICANT DILUTION despite being assured that the company was fully funded through to Feb 2021?

Am sure they will offer long term shareholders first rights as they are legally obligated to do as I understand as the vote to disapply pre-emption rights was voted DOWN?

[scottdavid70] 22/10/2020 18:01

Has anyone worked out if Tamarack and Hercules are completely in charge of the monetisation of Iclaprim why would
Lumsden deserve a bonus of $100,000 USD?

He is merely freeloading surely in that case? Grotesque amount unless someone can explain why he deserves a BONUS? Not just a salary for doing a job but something that deserves something EXTRA for supposedly doing better than he was asked? From where most of us are standing he has done a pretty poor job of protecting our investment wouldn’t you say?

[scottdavid70] 22/10/2020 07:30

2 days till it’s been a year since the much heralded US Army trials were shouted from the rooftops for Iclaprim. Nothing. Zero. Name one thing that Lumsden has done since the 14th February that has in anyway helped shareholders?

His idea of cost controls is very different to all of ours who keep getting diluted due to the company running out of money faster than it should have done if they hadn’t taken so much in salaries. Could have deferred their salaries to help leases the dilution but no that’s not the way greed works.

[scottdavid70] 21/10/2020 16:59

4 weeks from term sheet to deal is the time it took in general when I was in venture capital. Let’s see what the last week plus has in store for all of us....holders of shares.

Seeing as on the 12th October several had progressed to term sheet then it can’t be long....unless they are being economical with the truth?

[rapidlyprogressing] 21/10/2020 15:30

DdI? How's your mum?

[scottdavid70] 21/10/2020 12:43

Ddi you get the results back to see if you are Lumsdens love child while we are on the subject of children?

[rapidlyprogressing] 21/10/2020 10:15

3 days till it's been a year.... you sound like a child

[scottdavid70] 21/10/2020 09:29

3 days till it’s been a year since the much heralded US Army trials were shouted from the rooftops for Iclaprim. Nothing. Zero. Name one thing that Lumsden has done since the 14th February that has in anyway helped shareholders?

His idea of cost controls is very different to all of ours who keep getting diluted due to the company running out of money faster than it should have done if they hadn’t taken so much in salaries. Could have deferred their salaries to help leases the dilution but no that’s not the way greed works.

[scottdavid70] 19/10/2020 18:58

One of the Chapters in the “Dark Arts” is on how CEO’s contracts are sometimes as was the case here with Lumsden on 2/3rds of their salary being paid according to their ability to fundraise.

Therefore the quicker they run out of money and pay themselves a huge salary to help that process the more they make. It’s unbelievable when you research it as heavily as I have done for the book

[scottdavid70] 19/10/2020 09:06

It’s all in the book “The Dark Art of being a AIM CEO” coming to a Waterstones and Amazon audio as soon as the final
Chapter is written

[scottdavid70] 19/10/2020 09:05

They still want to pay Lumsden a BONUS and when you read those numbers can anyone say that he deserves it? After those salaries were paid the fees for investor and PR related services were paid??? Seriously how can he deserve a BONUS!!

[scottdavid70] 19/10/2020 09:04

Never forget what has gone on here with your investment!

[scottdavid70] 19/10/2020 09:04

Investor and public relations advisory fees

2020 US $120,000
2019 US $206,000
2018 US $629,000
2017 US $526,000

Can anyone tell me how you can spend US$ Over a half a million dollars in Investor and PR fess!!!!!! The GREEDOMETER has gone into the red zone

Still spent $120,000 last year? Yet can’t give a direct answer to a direct question

[scottdavid70] 19/10/2020 08:55

Just checking the Interims again to make sure I didn’t misread them:

Director fees, employee/consultant compensation, including share-based
payments

2020 US $332,000
2019 US $373,000
2018 US $1,522,000
2017 US $1,774,000

Incredible isn’t it? But more to come on the GREEDOMETER...